SEC Form 4 · accession 0001162194-18-000025
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen Christopher Linthwaite
Officer — President & CEO
Period of report
Feb 20, 2018
Accepted (ET)
Feb 22, 2018 · 4:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 20, 2018 | M | 4,750 | $0.00 | A | 119,702 | D | |
| Common Stock | Feb 20, 2018 | F | 1,938 | $7.81 | D | 117,764 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | — | Feb 20, 2018 | M | 4,750 | D | — | — | Common Stock | 4,750 | 55,417 | D |
Explanation of responses
- F1Includes 2,047 shares purchased on November 30, 2017 under the Company's 2017 Employee Stock Purchase Plan.
- F2Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit.
- F3On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date.